Cargando…
Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndrome
Clonidine, an α2-adrenergic receptor agonist, decreases circulating norepinephrine and epinephrine, attenuating sympathetic activity. Although catechol-O-methyltransferase (COMT) metabolizes catecholamines, main effectors of sympathetic function, COMT genetic variation effects on clonidine treatment...
Autores principales: | Hall, Kathryn T., Kossowsky, Joe, Oberlander, Tim F., Kaptchuk, Ted J., Saul, J. Philip, Wyller, Vegard Bruun, Fagermoen, Even, Sulheim, Dag, Gjerstad, Johannes, Winger, Anette, Mukamal, Kenneth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028250/ https://www.ncbi.nlm.nih.gov/pubmed/27457818 http://dx.doi.org/10.1038/tpj.2016.53 |
Ejemplares similares
-
Effects of low-dose clonidine on cardiovascular and autonomic variables in adolescents with chronic fatigue: a randomized controlled trial
por: Fagermoen, Even, et al.
Publicado: (2015) -
Clonidine in the treatment of adolescent chronic fatigue syndrome: a pilot study for the NorCAPITAL trial
por: Fagermoen, Even, et al.
Publicado: (2012) -
Orthostatic responses in adolescent chronic fatigue syndrome: contributions from expectancies as well as gravity
por: Wyller, Vegard Bruun, et al.
Publicado: (2014) -
Cognitive dysfunction in adolescents with chronic fatigue: a cross-sectional study
por: Sulheim, Dag, et al.
Publicado: (2015) -
Systemic exertion intolerance disease diagnostic criteria applied on an adolescent chronic fatigue syndrome cohort: evaluation of subgroup differences and prognostic utility
por: Asprusten, Tarjei Tørre, et al.
Publicado: (2018)